It has been described that Gal1 can block the in vitro secretion of pro-inflammatory cytokines (IL-2, IFN and TNFα) [12] and specifically that Gal1 decreases IL-6 production [13], the latter playing an important role in RA. This evidence concerns the gene LGALS1 and rheumatoid arthritis.